{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T22:06:49Z","timestamp":1794434809171,"version":"4.9.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T00:00:00Z","timestamp":1671408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T00:00:00Z","timestamp":1671408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81600063"],"award-info":[{"award-number":["81600063"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81470266"],"award-info":[{"award-number":["81470266"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004761","name":"Natural Science Foundation of Hunan Province, China","doi-asserted-by":"crossref","award":["2017JJ3484"],"award-info":[{"award-number":["2017JJ3484"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["2022M713520"],"award-info":[{"award-number":["2022M713520"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Natural Science Foundation of Xinjiang Uygur Autonomous Region","award":["2022D01C498"],"award-info":[{"award-number":["2022D01C498"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antimicrob Resist Infect Control"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The prevalence of carbapenem-resistant\n                      <jats:italic>Klebsiella pneumoniae<\/jats:italic>\n                      bloodstream infection (CRKP-BSI) is increasing worldwide. CRKP-BSI is associated with high rates of morbidity and mortality due to limited antibiotic choices. Here, we aim to identify the prevalence and risk factors for infection and mortality of CRKP BSI.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a retrospective study of the past data from January 1st, 2012 to December 31st, 2019 of adult patients with KP-BSI in Xiangya Hospital, China.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among the 706 incidences included in this study, 27.4% of them (212\/753) being CR-KP strains. The occurrence of CRKP-BSI was increased from 20.69 to 37.40% from 2012 to 2019. Hematologic malignancies and ICU acquired infection were identified to be substantial risk factors of carbapenem resistance. The overall 28-day mortality rates of CRKP-BSI patients was significantly higher than that of CSKP-BSI (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). Logistic regression analysis identified severe sepsis or septic shock incidents, inadequate empirical antimicrobial therapy and corticosteroids use preceding infection onset as the independent predictors of 28-day mortality of CRKP-BSI patients. However, high dose carbapenem combination therapy was identified as anticipated factors of low 28-day mortality.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The occurrence of CRKP-BSI was significantly increased during the study period. Hematologic malignancies and ICU acquired infection were associated with the development of CRKP BSI. Severe sepsis or septic shock incidents, inadequate empirical antimicrobial therapy and corticosteroids use preceding infection onset caused significant increase of mortality rates in CRKP-BSI patients. High dose carbapenem combination therapy was associated with better outcome.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13756-022-01204-w","type":"journal-article","created":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T03:03:08Z","timestamp":1671418988000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Risk factors and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary-care hospital in China: an eight-year retrospective study"],"prefix":"10.1186","volume":"11","author":[{"given":"Jie","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhui","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjun","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peipei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longxiang","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruichao","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinhua","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,19]]},"reference":[{"key":"1204_CR1","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jcrc.2019.04.019","volume":"52","author":"ZQ Jiang","year":"2019","unstructured":"Jiang ZQ, Wang SD, Feng DD, Zhang BX, Mao SH, Wu JN. Epidemiological risk factors for nosocomial bloodstream infections: a four-year retrospective study in China. J Crit Care. 2019;52:92\u20136. https:\/\/doi.org\/10.1016\/j.jcrc.2019.04.019.","journal-title":"J Crit Care"},{"issue":"1","key":"1204_CR2","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1128\/aac.01775-15","volume":"60","author":"AM Ocampo","year":"2016","unstructured":"Ocampo AM, Chen L, Cienfuegos AV, Roncancio G, Chavda KD, Kreiswirth BN, et al. A two-year surveillance in five Colombian Tertiary Care Hospitals reveals high frequency of non-CG258 clones of Carbapenem-resistant Klebsiella pneumoniae with distinct clinical characteristics. Antimicrob Agents Chemother. 2016;60(1):332\u201342. https:\/\/doi.org\/10.1128\/aac.01775-15.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"1204_CR3","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3109\/00365548.2014.985710","volume":"47","author":"CK Pau","year":"2015","unstructured":"Pau CK, Ma FF, Ip M, You JH. Characteristics and outcomes of Klebsiella pneumoniae bacteraemia in Hong Kong. Infect Dis (Lond, Engl). 2015;47(5):283\u20138. https:\/\/doi.org\/10.3109\/00365548.2014.985710.","journal-title":"Infect Dis (Lond, Engl)"},{"key":"1204_CR4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13756-016-0145-0","volume":"5","author":"L Tian","year":"2016","unstructured":"Tian L, Tan R, Chen Y, Sun J, Liu J, Qu H, et al. Epidemiology of Klebsiella pneumoniae bloodstream infections in a teaching hospital: factors related to the carbapenem resistance and patient mortality. Antimicrob Resist Infect Control. 2016;5:48. https:\/\/doi.org\/10.1186\/s13756-016-0145-0.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"1","key":"1204_CR5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jinf.2014.01.014","volume":"69","author":"SL Nielsen","year":"2014","unstructured":"Nielsen SL, Pedersen C, Jensen TG, Gradel KO, Kolmos HJ, Lassen AT. Decreasing incidence rates of bacteremia: a 9-year population-based study. J Infect. 2014;69(1):51\u20139. https:\/\/doi.org\/10.1016\/j.jinf.2014.01.014.","journal-title":"J Infect"},{"issue":"11","key":"1204_CR6","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.ajic.2015.06.023","volume":"43","author":"D Delle Rose","year":"2015","unstructured":"Delle Rose D, Sordillo P, Gini S, Cerva C, Boros S, Rezza G, et al. Microbiologic characteristics and predictors of mortality in bloodstream infections in intensive care unit patients: a 1-year, large, prospective surveillance study in 5 Italian hospitals. Am J Infect Control. 2015;43(11):1178\u201383. https:\/\/doi.org\/10.1016\/j.ajic.2015.06.023.","journal-title":"Am J Infect Control"},{"issue":"1","key":"1204_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12941-017-0191-3","volume":"16","author":"L Xu","year":"2017","unstructured":"Xu L, Sun X, Ma X. Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae. Ann Clin Microbiol Antimicrob. 2017;16(1):18. https:\/\/doi.org\/10.1186\/s12941-017-0191-3.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"4","key":"1204_CR8","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s10096-017-3160-z","volume":"37","author":"J Li","year":"2018","unstructured":"Li J, Ren J, Wang W, Wang G, Gu G, Wu X, et al. Risk factors and clinical outcomes of hypervirulent Klebsiella pneumoniae induced bloodstream infections. Eur J Clin Microbiol Infect Dis. 2018;37(4):679\u201389. https:\/\/doi.org\/10.1007\/s10096-017-3160-z.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6","key":"1204_CR9","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.1128\/aac.03007-15","volume":"60","author":"A Gomez-Simmonds","year":"2016","unstructured":"Gomez-Simmonds A, Nelson B, Eiras DP, Loo A, Jenkins SG, Whittier S, et al. Combination regimens for treatment of Carbapenem-resistant Klebsiella pneumoniae bloodstream infections. Antimicrob Agents Chemother. 2016;60(6):3601\u20137. https:\/\/doi.org\/10.1128\/aac.03007-15.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"1204_CR10","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jiph.2017.06.003","volume":"11","author":"ML Cristina","year":"2018","unstructured":"Cristina ML, Alicino C, Sartini M, Faccio V, Spagnolo AM, Bono VD, et al. Epidemiology, management, and outcome of carbapenem-resistant Klebsiella pneumoniae bloodstream infections in hospitals within the same endemic metropolitan area. J Infect Public Health. 2018;11(2):171\u20137. https:\/\/doi.org\/10.1016\/j.jiph.2017.06.003.","journal-title":"J Infect Public Health"},{"issue":"12","key":"1204_CR11","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1007\/s10096-019-03673-1","volume":"38","author":"F Hu","year":"2019","unstructured":"Hu F, Guo Y, Yang Y, Zheng Y, Wu S, Jiang X, et al. Resistance reported from China antimicrobial surveillance network (CHINET) in 2018. Eur J Clin Microbiol Infect Dis. 2019;38(12):2275\u201381. https:\/\/doi.org\/10.1007\/s10096-019-03673-1.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"1204_CR12","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s12879-018-3160-3","volume":"18","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Guo LY, Song WQ, Wang Y, Dong F, Liu G. Risk factors for carbapenem-resistant K. pneumoniae bloodstream infection and predictors of mortality in Chinese paediatric patients. BMC Infect Dis. 2018;18(1):248. https:\/\/doi.org\/10.1186\/s12879-018-3160-3.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"1204_CR13","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1128\/aac.01020-07","volume":"52","author":"MJ Schwaber","year":"2008","unstructured":"Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, Schwartz D, Leavitt A, Carmeli Y. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother. 2008;52(3):1028\u201333. https:\/\/doi.org\/10.1128\/aac.01020-07.","journal-title":"Antimicrob Agents Chemother"},{"key":"1204_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2019.11.014","author":"H Chang","year":"2019","unstructured":"Chang H, Wei J, Zhou W, Yan X, Cao X, Zuo L, et al. Risk factors and mortality for patients with Bloodstream infections of Klebsiella pneumoniae during 2014\u20132018: Clinical impact of carbapenem resistance in a large tertiary hospital of China. J Infect Public Health. 2019. https:\/\/doi.org\/10.1016\/j.jiph.2019.11.014.","journal-title":"J Infect Public Health"},{"issue":"2","key":"1204_CR15","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1179\/2047773215y.0000000004","volume":"109","author":"Y Jiao","year":"2015","unstructured":"Jiao Y, Qin Y, Liu J, Li Q, Dong Y, Shang Y, et al. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection\/colonization and predictors of mortality: a retrospective study. Pathogens Glob Health. 2015;109(2):68\u201374. https:\/\/doi.org\/10.1179\/2047773215y.0000000004.","journal-title":"Pathogens Glob Health"},{"issue":"1","key":"1204_CR16","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.cmi.2014.08.001","volume":"21","author":"S Amit","year":"2015","unstructured":"Amit S, Mishali H, Kotlovsky T, Schwaber MJ, Carmeli Y. Bloodstream infections among carriers of carbapenem-resistant Klebsiella pneumoniae: etiology, incidence and predictors. Clin Microbiol Infect. 2015;21(1):30\u20134. https:\/\/doi.org\/10.1016\/j.cmi.2014.08.001.","journal-title":"Clin Microbiol Infect"},{"key":"1204_CR17","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13756-017-0256-2","volume":"6","author":"X Zheng","year":"2017","unstructured":"Zheng X, Wang JF, Xu WL, Xu J, Hu J. Clinical and molecular characteristics, risk factors and outcomes of Carbapenem-resistant Klebsiella pneumoniae bloodstream infections in the intensive care unit. Antimicrob Resist Infect Control. 2017;6:102. https:\/\/doi.org\/10.1186\/s13756-017-0256-2.","journal-title":"Antimicrob Resist Infect Control"},{"key":"1204_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1472-6947-14-9","volume":"14","author":"M Du","year":"2014","unstructured":"Du M, Xing Y, Suo J, Liu B, Jia N, Huo R, et al. Real-time automatic hospital-wide surveillance of nosocomial infections and outbreaks in a large Chinese tertiary hospital. BMC Med Inform Decis Mak. 2014;14:9. https:\/\/doi.org\/10.1186\/1472-6947-14-9.","journal-title":"BMC Med Inform Decis Mak"},{"issue":"12","key":"1204_CR19","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1111\/j.1469-0691.2011.03514.x","volume":"17","author":"O Zarkotou","year":"2011","unstructured":"Zarkotou O, Pournaras S, Tselioti P, Dragoumanos V, Pitiriga V, Ranellou K, et al. Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment. Clin Microbiol Infect. 2011;17(12):1798\u2013803. https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03514.x.","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"1204_CR20","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","volume":"36","author":"TC Horan","year":"2008","unstructured":"Horan TC, Andrus M, Dudeck MA. CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5):309\u201332. https:\/\/doi.org\/10.1016\/j.ajic.2008.03.002.","journal-title":"Am J Infect Control"},{"issue":"Suppl 1","key":"1204_CR21","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1016\/j.cmi.2016.01.001","volume":"22","author":"FP Hu","year":"2016","unstructured":"Hu FP, Guo Y, Zhu DM, Wang F, Jiang XF, Xu YC, et al. Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005\u20132014. Clin Microbiol Infect. 2016;22(Suppl 1):S9-14. https:\/\/doi.org\/10.1016\/j.cmi.2016.01.001.","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"1204_CR22","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1556\/030.65.2018.039","volume":"65","author":"M Moghadampour","year":"2018","unstructured":"Moghadampour M, Salari-Jazi A, Faghri J. High rate of carbapenem-resistant Klebsiella pneumoniae detected from hospital equipments in Iran. Acta Microbiol Immunol Hung. 2018;65(4):529\u201338. https:\/\/doi.org\/10.1556\/030.65.2018.039.","journal-title":"Acta Microbiol Immunol Hung"},{"key":"1204_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2019.02.019","author":"A Chamieh","year":"2019","unstructured":"Chamieh A, El-Hajj G, Zmerli O, Afif C, Azar E. Carbapenem resistant organisms: a 9-year surveillance and trends at Saint George University Medical Center. J Infect Public Health. 2019. https:\/\/doi.org\/10.1016\/j.jiph.2019.02.019.","journal-title":"J Infect Public Health"},{"issue":"1","key":"1204_CR24","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1469-0691.2011.03478.x","volume":"18","author":"D Ben-David","year":"2012","unstructured":"Ben-David D, Kordevani R, Keller N, Tal I, Marzel A, Gal-Mor O, et al. Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections. Clin Microbiol Infect. 2012;18(1):54\u201360. https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03478.x.","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"1204_CR25","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1128\/jcm.03455-14","volume":"53","author":"A Gomez-Simmonds","year":"2015","unstructured":"Gomez-Simmonds A, Greenman M, Sullivan SB, Tanner JP, Sowash MG, Whittier S, et al. Population structure of Klebsiella pneumoniae causing bloodstream infections at a New York city Tertiary Care Hospital: diversification of multidrug-resistant isolates. J Clin Microbiol. 2015;53(7):2060\u20137. https:\/\/doi.org\/10.1128\/jcm.03455-14.","journal-title":"J Clin Microbiol"},{"key":"1204_CR26","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1186\/s12879-015-1152-0","volume":"15","author":"C Alicino","year":"2015","unstructured":"Alicino C, Giacobbe DR, Orsi A, Tassinari F, Trucchi C, Sarteschi G, et al. Trends in the annual incidence of carbapenem-resistant Klebsiella pneumoniae bloodstream infections: a 8-year retrospective study in a large teaching hospital in northern Italy. BMC Infect Dis. 2015;15:415. https:\/\/doi.org\/10.1186\/s12879-015-1152-0.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"1204_CR27","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1128\/aac.02166-13","volume":"58","author":"GL Daikos","year":"2014","unstructured":"Daikos GL, Tsaousi S, Tzouvelekis LS, Anyfantis I, Psichogiou M, Argyropoulou A, et al. Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems. Antimicrob Agents Chemother. 2014;58(4):2322\u20138. https:\/\/doi.org\/10.1128\/aac.02166-13.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"1204_CR28","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1128\/aac.04284-14","volume":"59","author":"KD Brizendine","year":"2015","unstructured":"Brizendine KD, Richter SS, Cober ED, van Duin D. Carbapenem-resistant Klebsiella pneumoniae urinary tract infection following solid organ transplantation. Antimicrob Agents Chemother. 2015;59(1):553\u20137. https:\/\/doi.org\/10.1128\/aac.04284-14.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"1204_CR29","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13756-020-00728-3","volume":"9","author":"Y Li","year":"2020","unstructured":"Li Y, Li J, Hu T, Hu J, Song N, Zhang Y, et al. Five-year change of prevalence and risk factors for infection and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary hospital in North China. Antimicrob Resist Infect Control. 2020;9(1):79. https:\/\/doi.org\/10.1186\/s13756-020-00728-3.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"3","key":"1204_CR30","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3855\/jidc.6697","volume":"10","author":"Y Hu","year":"2016","unstructured":"Hu Y, Ping Y, Li L, Xu H, Yan X, Dai H. A retrospective study of risk factors for carbapenem-resistant Klebsiella pneumoniae acquisition among ICU patients. J Infect Dev Ctries. 2016;10(3):208\u201313. https:\/\/doi.org\/10.3855\/jidc.6697.","journal-title":"J Infect Dev Ctries"},{"issue":"4","key":"1204_CR31","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11908-017-0575-8","volume":"19","author":"J Daniel Markley","year":"2017","unstructured":"Daniel Markley J, Bernard S, Bearman G, Stevens MP. De-escalating antibiotic use in the inpatient setting: strategies, controversies, and challenges. Curr Infect Dis Rep. 2017;19(4):17. https:\/\/doi.org\/10.1007\/s11908-017-0575-8.","journal-title":"Curr Infect Dis Rep"},{"issue":"4","key":"1204_CR32","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1086\/675611","volume":"35","author":"BM Brennan","year":"2014","unstructured":"Brennan BM, Coyle JR, Marchaim D, Pogue JM, Boehme M, Finks J, et al. Statewide surveillance of carbapenem-resistant enterobacteriaceae in Michigan. Infect Control Hosp Epidemiol. 2014;35(4):342\u20139. https:\/\/doi.org\/10.1086\/675611.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"4","key":"1204_CR33","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.jhin.2012.10.012","volume":"83","author":"K Hussein","year":"2013","unstructured":"Hussein K, Raz-Pasteur A, Finkelstein R, Neuberger A, Shachor-Meyouhas Y, Oren I, et al. Impact of carbapenem resistance on the outcome of patients\u2019 hospital-acquired bacteraemia caused by Klebsiella pneumoniae. J Hosp Infect. 2013;83(4):307\u201313. https:\/\/doi.org\/10.1016\/j.jhin.2012.10.012.","journal-title":"J Hosp Infect"},{"issue":"3","key":"1204_CR34","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/inf.0000000000000987","volume":"35","author":"A Diaz","year":"2016","unstructured":"Diaz A, Ortiz DC, Trujillo M, Garces C, Jaimes F, Restrepo AV. Clinical characteristics of carbapenem-resistant Klebsiella pneumoniae Infections in Ill and colonized children in Colombia. Pediatr Infect Dis J. 2016;35(3):237\u201341. https:\/\/doi.org\/10.1097\/inf.0000000000000987.","journal-title":"Pediatr Infect Dis J"},{"issue":"7\u20138","key":"1204_CR35","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1080\/20477724.2016.1254976","volume":"110","author":"F Akgul","year":"2016","unstructured":"Akgul F, Bozkurt I, Sunbul M, Esen S, Leblebicioglu H. Risk factors and mortality in the Carbapenem-resistant Klebsiella pneumoniae infection: case control study. Pathog Glob Health. 2016;110(7\u20138):321\u20135. https:\/\/doi.org\/10.1080\/20477724.2016.1254976.","journal-title":"Pathog Glob Health"},{"key":"1204_CR36","doi-asserted-by":"publisher","first-page":"219","DOI":"10.12659\/msm.892516","volume":"21","author":"A Candevir-Ulu","year":"2015","unstructured":"Candevir-Ulu A, Kurtaran B, Inal AS, Komur S, Kibar F, Yapici-Cicekdemir H, et al. Risk factors of carbapenem-resistant Klebsiella pneumoniae infection: a serious threat in ICUs. Med Sci Monit Int Med J Exp Clin Res. 2015;21:219\u201324. https:\/\/doi.org\/10.12659\/msm.892516.","journal-title":"Med Sci Monit Int Med J Exp Clin Res"},{"issue":"7","key":"1204_CR37","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s10096-017-2899-6","volume":"36","author":"M Papadimitriou-Olivgeris","year":"2017","unstructured":"Papadimitriou-Olivgeris M, Fligou F, Bartzavali C, Zotou A, Spyropoulou A, Koutsileou K, et al. Carbapenemase-producing Klebsiella pneumoniae bloodstream infection in critically ill patients: risk factors and predictors of mortality. Eur J Clin Microbiol Infect Dis. 2017;36(7):1125\u201331. https:\/\/doi.org\/10.1007\/s10096-017-2899-6.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"10","key":"1204_CR38","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1093\/jac\/dkv200","volume":"70","author":"M Tumbarello","year":"2015","unstructured":"Tumbarello M, Viale P, Bassetti M, De Rosa FG, Spanu T, Viscoli C. Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study\u2013authors\u2019 response. J Antimicrob Chemother. 2015;70(10):2922. https:\/\/doi.org\/10.1093\/jac\/dkv200.","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"1204_CR39","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00134-012-2769-8","volume":"39","author":"RP Dellinger","year":"2013","unstructured":"Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39(2):165\u2013228. https:\/\/doi.org\/10.1007\/s00134-012-2769-8.","journal-title":"Intensive Care Med"},{"issue":"4","key":"1204_CR40","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1093\/jac\/dkv414","volume":"71","author":"Y Fraenkel-Wandel","year":"2016","unstructured":"Fraenkel-Wandel Y, Raveh-Brawer D, Wiener-Well Y, Yinnon AM, Assous MV. Mortality due to blaKPC Klebsiella pneumoniae bacteraemia. J Antimicrob Chemother. 2016;71(4):1083\u20137. https:\/\/doi.org\/10.1093\/jac\/dkv414.","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"1204_CR41","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ijantimicag.2017.08.019","volume":"51","author":"M Giannella","year":"2018","unstructured":"Giannella M, Trecarichi EM, Giacobbe DR, De Rosa FG, Bassetti M, Bartoloni A, et al. Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection. Int J Antimicrob Agents. 2018;51(2):244\u20138. https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.08.019.","journal-title":"Int J Antimicrob Agents"},{"key":"1204_CR42","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.3389\/fmicb.2017.01061","volume":"8","author":"B Zheng","year":"2017","unstructured":"Zheng B, Dai Y, Liu Y, Shi W, Dai E, Han Y, et al. Molecular Epidemiology and risk factors of Carbapenem-Resistant Klebsiella pneumoniae infections in eastern China. Front Microbiol. 2017;8:1061. https:\/\/doi.org\/10.3389\/fmicb.2017.01061.","journal-title":"Front Microbiol"}],"container-title":["Antimicrobial Resistance &amp; Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-022-01204-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13756-022-01204-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-022-01204-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T03:08:04Z","timestamp":1671419284000},"score":1,"resource":{"primary":{"URL":"https:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-022-01204-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,19]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1204"],"URL":"https:\/\/doi.org\/10.1186\/s13756-022-01204-w","relation":{},"ISSN":["2047-2994"],"issn-type":[{"value":"2047-2994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,19]]},"assertion":[{"value":"26 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Xiangya Hospital, Central South University (No. 202104005). Due to the nature of the retrospective study and the anonymous processing of data prior to analysis, the Ethics Committee approved the waiver of informed consent. The study we carried out strictly complies with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None of authors declare conflicts of interest relevant to this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"161"}}